nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—ADRB2—dilated cardiomyopathy	0.821	1	CbGaD
Ephedrine—Prostatic hypertrophy—Furosemide—dilated cardiomyopathy	0.0285	0.212	CcSEcCtD
Ephedrine—Acute retention of urine—Furosemide—dilated cardiomyopathy	0.0256	0.191	CcSEcCtD
Ephedrine—Benign prostatic hyperplasia—Furosemide—dilated cardiomyopathy	0.0155	0.115	CcSEcCtD
Ephedrine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00263	0.0196	CcSEcCtD
Ephedrine—Lightheadedness—Furosemide—dilated cardiomyopathy	0.0024	0.0179	CcSEcCtD
Ephedrine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00208	0.0154	CcSEcCtD
Ephedrine—ADRB2—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00192	0.0499	CbGpPWpGaD
Ephedrine—Irritability—Furosemide—dilated cardiomyopathy	0.00186	0.0139	CcSEcCtD
Ephedrine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00185	0.0138	CcSEcCtD
Ephedrine—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.0018	0.0134	CcSEcCtD
Ephedrine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00178	0.0132	CcSEcCtD
Ephedrine—ADRA1A—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.00159	0.0413	CbGpPWpGaD
Ephedrine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00145	0.0108	CcSEcCtD
Ephedrine—Sweating—Furosemide—dilated cardiomyopathy	0.00144	0.0107	CcSEcCtD
Ephedrine—Irritability—Lisinopril—dilated cardiomyopathy	0.0014	0.0104	CcSEcCtD
Ephedrine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00139	0.0104	CcSEcCtD
Ephedrine—ADRA1A—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.00129	0.0334	CbGpPWpGaD
Ephedrine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00123	0.00917	CcSEcCtD
Ephedrine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00121	0.00897	CcSEcCtD
Ephedrine—Dysuria—Lisinopril—dilated cardiomyopathy	0.00118	0.0088	CcSEcCtD
Ephedrine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00117	0.00867	CcSEcCtD
Ephedrine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00113	0.0084	CcSEcCtD
Ephedrine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00112	0.00834	CcSEcCtD
Ephedrine—Rash—Spironolactone—dilated cardiomyopathy	0.00111	0.00827	CcSEcCtD
Ephedrine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00111	0.00826	CcSEcCtD
Ephedrine—Headache—Spironolactone—dilated cardiomyopathy	0.0011	0.00821	CcSEcCtD
Ephedrine—Sweating—Lisinopril—dilated cardiomyopathy	0.00108	0.00804	CcSEcCtD
Ephedrine—Agitation—Furosemide—dilated cardiomyopathy	0.00108	0.00803	CcSEcCtD
Ephedrine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00106	0.0275	CbGpPWpGaD
Ephedrine—ACHE—Glycerophospholipid biosynthesis—TAZ—dilated cardiomyopathy	0.00106	0.0274	CbGpPWpGaD
Ephedrine—Vertigo—Furosemide—dilated cardiomyopathy	0.00106	0.00785	CcSEcCtD
Ephedrine—Nausea—Spironolactone—dilated cardiomyopathy	0.00105	0.00779	CcSEcCtD
Ephedrine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00103	0.00767	CcSEcCtD
Ephedrine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00101	0.0075	CcSEcCtD
Ephedrine—Confusional state—Furosemide—dilated cardiomyopathy	0.000967	0.00719	CcSEcCtD
Ephedrine—BCHE—Glycerophospholipid biosynthesis—TAZ—dilated cardiomyopathy	0.000943	0.0245	CbGpPWpGaD
Ephedrine—Phenylpropanolamine—ADRB1—dilated cardiomyopathy	0.000936	0.164	CrCbGaD
Ephedrine—Amphetamine—SLC22A5—dilated cardiomyopathy	0.000929	0.162	CrCbGaD
Ephedrine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000927	0.0069	CcSEcCtD
Ephedrine—ACHE—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000921	0.0239	CbGpPWpGaD
Ephedrine—Anorexia—Furosemide—dilated cardiomyopathy	0.000914	0.0068	CcSEcCtD
Ephedrine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000905	0.00673	CcSEcCtD
Ephedrine—Tension—Lisinopril—dilated cardiomyopathy	0.000865	0.00643	CcSEcCtD
Ephedrine—Methamphetamine—SLC22A5—dilated cardiomyopathy	0.000861	0.151	CrCbGaD
Ephedrine—Nervousness—Lisinopril—dilated cardiomyopathy	0.000856	0.00637	CcSEcCtD
Ephedrine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000847	0.0063	CcSEcCtD
Ephedrine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000833	0.0062	CcSEcCtD
Ephedrine—Tremor—Lisinopril—dilated cardiomyopathy	0.000826	0.00614	CcSEcCtD
Ephedrine—Pain—Furosemide—dilated cardiomyopathy	0.00082	0.0061	CcSEcCtD
Ephedrine—Vertigo—Lisinopril—dilated cardiomyopathy	0.000792	0.00589	CcSEcCtD
Ephedrine—Pseudoephedrine—ADRB1—dilated cardiomyopathy	0.000791	0.138	CrCbGaD
Ephedrine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00079	0.00588	CcSEcCtD
Ephedrine—Phenylpropanolamine—ADRB2—dilated cardiomyopathy	0.000787	0.138	CrCbGaD
Ephedrine—Palpitations—Lisinopril—dilated cardiomyopathy	0.000779	0.0058	CcSEcCtD
Ephedrine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000758	0.00564	CcSEcCtD
Ephedrine—Pseudoephedrine—TNF—dilated cardiomyopathy	0.000751	0.131	CrCbGaD
Ephedrine—Chest pain—Lisinopril—dilated cardiomyopathy	0.00075	0.00558	CcSEcCtD
Ephedrine—Anxiety—Lisinopril—dilated cardiomyopathy	0.000748	0.00556	CcSEcCtD
Ephedrine—ACHE—Phospholipid metabolism—TAZ—dilated cardiomyopathy	0.000738	0.0191	CbGpPWpGaD
Ephedrine—Confusional state—Lisinopril—dilated cardiomyopathy	0.000725	0.0054	CcSEcCtD
Ephedrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000713	0.0185	CbGpPWpGaD
Ephedrine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000702	0.00522	CcSEcCtD
Ephedrine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000695	0.00517	CcSEcCtD
Ephedrine—Asthenia—Furosemide—dilated cardiomyopathy	0.000688	0.00512	CcSEcCtD
Ephedrine—Anorexia—Lisinopril—dilated cardiomyopathy	0.000686	0.0051	CcSEcCtD
Ephedrine—ADRB2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00068	0.0176	CbGpPWpGaD
Ephedrine—Pseudoephedrine—ADRB2—dilated cardiomyopathy	0.000665	0.116	CrCbGaD
Ephedrine—BCHE—Phospholipid metabolism—TAZ—dilated cardiomyopathy	0.000658	0.0171	CbGpPWpGaD
Ephedrine—Insomnia—Lisinopril—dilated cardiomyopathy	0.000651	0.00484	CcSEcCtD
Ephedrine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000641	0.00477	CcSEcCtD
Ephedrine—Dizziness—Furosemide—dilated cardiomyopathy	0.000634	0.00472	CcSEcCtD
Ephedrine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000633	0.00471	CcSEcCtD
Ephedrine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000625	0.00465	CcSEcCtD
Ephedrine—Pain—Lisinopril—dilated cardiomyopathy	0.000615	0.00458	CcSEcCtD
Ephedrine—Vomiting—Furosemide—dilated cardiomyopathy	0.00061	0.00454	CcSEcCtD
Ephedrine—Rash—Furosemide—dilated cardiomyopathy	0.000605	0.0045	CcSEcCtD
Ephedrine—Dermatitis—Furosemide—dilated cardiomyopathy	0.000604	0.00449	CcSEcCtD
Ephedrine—Headache—Furosemide—dilated cardiomyopathy	0.000601	0.00447	CcSEcCtD
Ephedrine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000593	0.00441	CcSEcCtD
Ephedrine—ADRB2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000572	0.0148	CbGpPWpGaD
Ephedrine—Nausea—Furosemide—dilated cardiomyopathy	0.000569	0.00424	CcSEcCtD
Ephedrine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000569	0.00423	CcSEcCtD
Ephedrine—ADRA1A—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000563	0.0146	CbGpPWpGaD
Ephedrine—ADRA1A—Endothelin Pathways—ADRB1—dilated cardiomyopathy	0.000563	0.0146	CbGpPWpGaD
Ephedrine—ADRB2—Arf6 signaling events—AGTR1—dilated cardiomyopathy	0.000554	0.0144	CbGpPWpGaD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000529	0.0137	CbGpPWpGaD
Ephedrine—Asthenia—Lisinopril—dilated cardiomyopathy	0.000516	0.00384	CcSEcCtD
Ephedrine—ACHE—Monoamine Transport—AGT—dilated cardiomyopathy	0.000511	0.0133	CbGpPWpGaD
Ephedrine—SLC6A2—Monoamine Transport—AGT—dilated cardiomyopathy	0.000506	0.0131	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000481	0.0125	CbGpPWpGaD
Ephedrine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000476	0.00354	CcSEcCtD
Ephedrine—ADRA1A—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.000473	0.0123	CbGpPWpGaD
Ephedrine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000457	0.0034	CcSEcCtD
Ephedrine—ADRA1A—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000456	0.0118	CbGpPWpGaD
Ephedrine—Rash—Lisinopril—dilated cardiomyopathy	0.000454	0.00337	CcSEcCtD
Ephedrine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000453	0.00337	CcSEcCtD
Ephedrine—Headache—Lisinopril—dilated cardiomyopathy	0.000451	0.00335	CcSEcCtD
Ephedrine—ADRB2—Arf6 trafficking events—AGTR1—dilated cardiomyopathy	0.000438	0.0114	CbGpPWpGaD
Ephedrine—ADRB2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000431	0.0112	CbGpPWpGaD
Ephedrine—Nausea—Lisinopril—dilated cardiomyopathy	0.000427	0.00318	CcSEcCtD
Ephedrine—SLC18A2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000423	0.011	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000419	0.0109	CbGpPWpGaD
Ephedrine—ADRB2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000419	0.0109	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000405	0.0105	CbGpPWpGaD
Ephedrine—ADRB2—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	0.000401	0.0104	CbGpPWpGaD
Ephedrine—ADRA1A—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000383	0.00994	CbGpPWpGaD
Ephedrine—ACHE—Peptide hormone metabolism—ACE—dilated cardiomyopathy	0.000369	0.00958	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00036	0.00934	CbGpPWpGaD
Ephedrine—ADRA1A—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000356	0.00924	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000347	0.009	CbGpPWpGaD
Ephedrine—ADRA1A—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.000346	0.00899	CbGpPWpGaD
Ephedrine—BCHE—Peptide hormone metabolism—ACE—dilated cardiomyopathy	0.000329	0.00855	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000324	0.0084	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000321	0.00833	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.000312	0.00809	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—ABCC9—dilated cardiomyopathy	0.000288	0.00747	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000287	0.00745	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—ACTN2—dilated cardiomyopathy	0.000276	0.00716	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—ABCC9—dilated cardiomyopathy	0.000257	0.00666	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000253	0.00655	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000251	0.00652	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—ACTN2—dilated cardiomyopathy	0.000246	0.00639	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000245	0.00634	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000245	0.00634	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000237	0.00616	CbGpPWpGaD
Ephedrine—ADRB2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.000236	0.00612	CbGpPWpGaD
Ephedrine—ADRA1A—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.000235	0.00609	CbGpPWpGaD
Ephedrine—ACHE—Peptide hormone metabolism—AGT—dilated cardiomyopathy	0.000234	0.00607	CbGpPWpGaD
Ephedrine—ACHE—Monoamine Transport—TNF—dilated cardiomyopathy	0.000232	0.00601	CbGpPWpGaD
Ephedrine—SLC6A2—Monoamine Transport—TNF—dilated cardiomyopathy	0.000229	0.00594	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000227	0.0059	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000225	0.00584	CbGpPWpGaD
Ephedrine—ADRA1A—AMPK Signaling—RPS6KB1—dilated cardiomyopathy	0.000217	0.00563	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000212	0.0055	CbGpPWpGaD
Ephedrine—BCHE—Peptide hormone metabolism—AGT—dilated cardiomyopathy	0.000209	0.00542	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000205	0.00532	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000205	0.00532	CbGpPWpGaD
Ephedrine—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000204	0.00528	CbGpPWpGaD
Ephedrine—ADRB2—Arf6 signaling events—EGFR—dilated cardiomyopathy	0.000186	0.00481	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (12/13) signalling events—RAC1—dilated cardiomyopathy	0.000183	0.00476	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.000183	0.00475	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.000183	0.00475	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000169	0.00439	CbGpPWpGaD
Ephedrine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000168	0.00437	CbGpPWpGaD
Ephedrine—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000168	0.00436	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000165	0.00427	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000165	0.00427	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000153	0.00397	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000146	0.00378	CbGpPWpGaD
Ephedrine—ADRA1A—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.000139	0.00361	CbGpPWpGaD
Ephedrine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.000136	0.00354	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000136	0.00352	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000136	0.00352	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000131	0.0034	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000131	0.00339	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000128	0.00333	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000125	0.00324	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000125	0.00324	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000121	0.00313	CbGpPWpGaD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00012	0.00312	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00012	0.00311	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000116	0.00301	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ANKRD1—dilated cardiomyopathy	0.000112	0.00292	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000112	0.00292	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000112	0.00291	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000112	0.00291	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000109	0.00282	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000107	0.00278	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—TAZ—dilated cardiomyopathy	0.000106	0.00274	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000103	0.00268	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000103	0.00268	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ANKRD1—dilated cardiomyopathy	0.0001	0.0026	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	9.6e-05	0.00249	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	9.6e-05	0.00249	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—SDHA—dilated cardiomyopathy	9.56e-05	0.00248	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	9.51e-05	0.00247	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	9.51e-05	0.00247	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—TAZ—dilated cardiomyopathy	9.43e-05	0.00245	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	9.3e-05	0.00241	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	9.27e-05	0.00241	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—RAF1—dilated cardiomyopathy	9.22e-05	0.00239	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	8.84e-05	0.00229	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	8.8e-05	0.00228	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	8.56e-05	0.00222	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—SDHA—dilated cardiomyopathy	8.53e-05	0.00221	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	8.5e-05	0.00221	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	8.44e-05	0.00219	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	8.19e-05	0.00213	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—LMNA—dilated cardiomyopathy	8.08e-05	0.0021	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	7.94e-05	0.00206	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	7.87e-05	0.00204	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	7.87e-05	0.00204	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	7.55e-05	0.00196	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	7.54e-05	0.00196	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	7.31e-05	0.0019	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	7.31e-05	0.0019	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	7.31e-05	0.0019	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—LMNA—dilated cardiomyopathy	7.21e-05	0.00187	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	7.08e-05	0.00184	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—ACE—dilated cardiomyopathy	6.97e-05	0.00181	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	6.76e-05	0.00175	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—RAF1—dilated cardiomyopathy	6.28e-05	0.00163	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—ACE—dilated cardiomyopathy	6.22e-05	0.00161	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	6.05e-05	0.00157	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.83e-05	0.00151	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	5.83e-05	0.00151	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	5.74e-05	0.00149	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.68e-05	0.00147	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—RAF1—dilated cardiomyopathy	5.6e-05	0.00145	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	5.59e-05	0.00145	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	5.55e-05	0.00144	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	5.37e-05	0.00139	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	5.37e-05	0.00139	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	5.24e-05	0.00136	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.2e-05	0.00135	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	5.15e-05	0.00134	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.12e-05	0.00133	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.07e-05	0.00131	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	5e-05	0.0013	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.96e-05	0.00129	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.88e-05	0.00127	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.88e-05	0.00127	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4.84e-05	0.00126	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.56e-05	0.00118	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.54e-05	0.00118	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	4.45e-05	0.00115	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	4.45e-05	0.00115	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—AGT—dilated cardiomyopathy	4.42e-05	0.00115	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	4.39e-05	0.00114	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	4.26e-05	0.0011	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	4.13e-05	0.00107	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	4.13e-05	0.00107	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.04e-05	0.00105	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.04e-05	0.00105	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	4e-05	0.00104	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—AGT—dilated cardiomyopathy	3.94e-05	0.00102	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.75e-05	0.000974	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.75e-05	0.000974	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.63e-05	0.000943	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	3.59e-05	0.000932	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.42e-05	0.000887	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.34e-05	0.000866	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.25e-05	0.000842	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.24e-05	0.000841	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.1e-05	0.000805	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.04e-05	0.00079	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.95e-05	0.000764	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.91e-05	0.000754	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.88e-05	0.000748	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.88e-05	0.000748	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.76e-05	0.000717	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.69e-05	0.000697	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.68e-05	0.000695	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	2.64e-05	0.000685	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GPX1—dilated cardiomyopathy	2.6e-05	0.000674	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.6e-05	0.000673	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CD36—dilated cardiomyopathy	2.53e-05	0.000656	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.52e-05	0.000653	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.41e-05	0.000624	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.38e-05	0.000619	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.38e-05	0.000619	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GPX1—dilated cardiomyopathy	2.32e-05	0.000601	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.29e-05	0.000593	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AGT—dilated cardiomyopathy	2.28e-05	0.000591	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CD36—dilated cardiomyopathy	2.26e-05	0.000586	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.22e-05	0.000575	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.22e-05	0.000575	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	2.18e-05	0.000567	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.15e-05	0.000557	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AGT—dilated cardiomyopathy	2.03e-05	0.000527	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.83e-05	0.000476	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.83e-05	0.000475	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.81e-05	0.000469	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.74e-05	0.000451	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	1.63e-05	0.000424	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	1.56e-05	0.000405	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.52e-05	0.000393	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.49e-05	0.000388	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	1.35e-05	0.00035	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	1.29e-05	0.000335	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.26e-05	0.000326	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.08e-05	0.000281	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.04e-05	0.00027	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	8.96e-06	0.000232	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	7.43e-06	0.000193	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	6.14e-06	0.000159	CbGpPWpGaD
